A nanoparticle-based immobilization assay for prion-kinetics study

Journal of Nanobiotechnology

Volumn 4, Issue , 2006, Pages

  Kouassi, Gilles K ^a   Irudayaraj, Joseph ^b  

^a 229 Agricultural Engineering Building   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PRECIPITATION (CHEMICAL); REACTION KINETICS; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY;

HYDROXYSUCCINIMIDE; NANOARTICLE-BASED IMMOBILIZATION ASSAY; PRION-KINETICS;

NANOTECHNOLOGY;

AMINO ACID; ASPARTIC ACID; CARBOXYL GROUP; CYANAMIDE; FERRIC CHLORIDE; FERROUS CHLORIDE; GOLD; NANOPARTICLE; PRION PROTEIN; SUCCINIMIDE DERIVATIVE;

ARTICLE; BINDING KINETICS; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; INFRARED SPECTROSCOPY; MATERIAL COATING; MICELLE; PARTICLE SIZE; PRECIPITATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33749422892     PISSN: 14773155     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-4-8     Document Type: Article

References (26)

1. Cohen FE, Kelly JW: Therapeutic approaches to protein misfolding diseases. Nature 2003, 426:905-909.
2. Brown DR. Qin K, Herms JW, Madlung A, Manson J, Strome R. Fraser PE, Kruck T, Schlulz-Shaeffer W, Giese A, Westaway D, Kretzchmar H: The cellular prion protein binds copper in vivo. Nature 1997, 390:684-987.
3. Levy Y, Becker OM: Conformational polymorphism of wildtype and mutant rion proteins: Energy landscape analysis. Proteins, structure, function and genetics 2002, 47:458-468.
4. Apetri AC, Surewicz WK: Atypical effect of salts on the thermodynamics stability of human prion protein. J Biol Chem 2003, 278:22187-22191.
5. Prusinier SB, Scott MR, DeArmond SJ, Cohen FE: Prion protein biology. Cell 1998, 93:337-348.
6. Cui T, Daniels M, Wong BS, Li R, Sassoon J, Brown D: Mapping the functional domain of the prion protein. Eur J Biochem 2003, 270:3368-3376.
7. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochem 2000, 39:13760-13771.
8. Leclerc E, Peretz D, Ball H, Sakurai H, Legname G, Serban A, Prusiner SB, Burton D, Williamson RA: Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form. EMBO J 2001, 20:1547-1554.
9. Welesmith JW: Preliminary epidemiological analyses of the first 16 cases of the BSE born after July 1996. Vet Rec 2002, 151:451-452.
10. Kuehn BM: Canada wraps up BSE investigation. J Am Vet Assoc 2003, 223:919-921.
11. Gupta PD, Dave M, Vasavada AR: Protein Nanotechnology- a powerful futuristic diagnostic technique. Ind J Clin Biochem 2005, 20:48-53.
12. Fancy DA: Elucidation of protein-protein interaction using chemical cross-linking or label transfer techniques. Curr Opin Chem Biol 2000, 4:28-33.
13. Damborský J: Quantitative structure-function and structure-stability relationship of purposely modified proteins. Protein Eng 1998, 11:21-30.
14. Rucker VC, Havenstrite KL, Simmons BA, Sickafoose SM, Herr AE, Shediac R: Functional antibody immobilization and 3-dimentional polymeric surface generated by reactive ion etching. Longmuir 2005, 21:7621-7625.
15. Bussow K, Konthur Z, Lueking A, Lehrach H, Walter G: Protein array technology, potential use in medical Diagnostics. Am J Pharmacogenomics 2001, 1:1175-2203.
16. Huang SH, Liao MH, Chen DH: Direct binding and characterization of lipase onto magnetic nanoparticles. Biotechnol Prog 2003, 19:1095-1100.
17. Koneracka M, Kokcansky P, Antalik M, Timko M, Ramchand CN, Lobo D, Mehta R, Upadhyay RV: Immobilization of proteins and enzymes to fine magnetic particles. J Magn Mater 1999, 201:427-430.
18. Niemeyer CM: Nanoparticles, proteins, and nucleic acid: Biotechnology meets materials science. Angew Chem In Ed 2001, 4:4128-4148.
19. Minard-Basquin C, Kögler R, Matsuzawa NN, Yasuda A: Gold-nanoparticles-assisted oligonucleotides immobilization for improved DNA detection. IEEE Proc-Nanotechnol 2005, 152:97-103.
20. Demers LM, Mirkin CA, Mucic RC, Reynolds RA, Leitsinger RL, Viswanadham G: A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiolcapped oligonucleotides bound to gold thin films and nanoparticles. Anal Chem 2000, 72:5535-5541.
21. Kouassi KG, Irudayaraj J, McCarthy G: Examination of cholesterol oxidase immobilization onto magnetic nanoparticles. Biomagnetic Res Technol 2005, 3:1.
22. Jun L, Zhou W, Kumbhar J, Wiemann J, Fang J, Carpentier EE, O'Connor CJ: Gold coated iron (FeΑu) nanoparticles. synthesis, characterization, and magnetic field induced self-assembly. J Solid State Chem 2001, 159:26-31.
23. Mikhaylova M, Kim KD, Berry CC, Zogorodni A, Toprak M, Curtis ASG, Muhammed M: BSA immobilization on amine-functionalized superparamagnetic iron oxide nanoparticles. Chem Mater 2004, 16:2344-2354.
24. Rivas L, Sanchez-Cortes S, Garcia-Ramos JV, Morrcillo G: Mixed silver/ gold colloids: A study of their formation, morphology, and surface enhanced raman activity. Langmuir 2000, 16:9722-9728.
25. Fischer MB, Roecki C, Parizek P, Schwarz HP, Aguzzi A: Binding of disease associated prion protein to plasminogen. Nature 2000, 408:479-483.
26. Deignan ME, Prior M, Stuart LE, Comerford EJ, McMahon EM: The structure function relationship for the prion protein. Journal of Alzheimer's Disease 2004, 6:283-289.